CCEL logo

Cryo-Cell International (CCEL)

Profile

Full Name

Cryo-Cell International, Inc.

Ticker Symbol

CCEL

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Care Facilities

Country

United States

IPO

April 4, 1994

Indexes

Not included

Website

http://www.cryo-cell.com

Employees

82

Key Details

Price

$6.03(+9.44%)

Market cap

Last Dividend

$0.25

TTM Dividend yield

4.15%

Annual revenue

$31.99M(+2.05% YoY)

Annual EPS

$0.05(+104.35% YoY)

PE ratio

603.00

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$6.03
CCEL price is $6.03

30-Day Relative Volume

0.58
CCEL 30-day relative volume is 0.58

Price Performance

Price Most recent change

+9.44%
CCEL price was up +9.44% on Apr 16, 2025

Price YTD change

-18.62%
CCEL price is down -18.62% since January 1st

Price 1-year change

-10.67%
CCEL price is down -10.67% year-on-year

Price 3-year change

-12.99%
CCEL price is down -12.99% over the past 3 years

Price Range

Price All-time high

$14.16
CCEL price is currently -57.42% below its historical high of $14.16

Price 3-year low

$2.69
CCEL price is currently +124.16% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$48.74M
CCEL market capitalization is $48.74 million

Market cap 3-year change

-16.88%
CCEL market capitalization is down -16.88% over the past 3 years

Market cap All-time high

$120.78M
CCEL market capitalization is currently -59.65% below its historical high of $120.78 million

Market cap sector rank

37.83%
CCEL market capitalization is higher than 37.83% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-2.09%
CCEL shares outstanding is down -2.09% year-on-year

Shares Outstanding 3-Year Change

-4.47%
CCEL shares outstanding is down -4.47% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.09
CCEL beta is 0.09

200-day SMA

$7.14
CCEL price is currently -15.57% below its 200-day simple moving average

50-day SMA

$6.81
CCEL price is currently -11.44% below its 50-day simple moving average

RSI

47.74
CCEL 14-day relative strength index is 47.74

Volume

0.58
CCEL 30-day relative volume is 0.58

ATR

$0.43
CCEL average true range is $0.43

10-day Historical Volatility

101.95%
CCEL 10-day historical volatility is 101.95%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.25
CCEL last dividend was $0.25 per share, with an ex-dividend date of February 14, 2025

Next Dividend

-
CCEL next dividend has not yet been announced

Dividend per share

Dividend per share

$0.25
CCEL annual dividend per share is $0.25

Dividend per share Sector Rank

12.79%
CCEL annual dividend per share is higher than 12.79% of companies in Healthcare sector

Dividend per share 1-Year Change

-72.22%
CCEL annual dividend per share is down -72.22% year-on-year

Dividend per share 3-Year Change

-
CCEL annual dividend per share 3-year change is unknown

Dividend yield

Dividend yield

4.15%
CCEL annual dividend yield is 4.15%

Dividend yield Sector Rank

76.47%
CCEL annual dividend yield is higher than 76.47% of companies in Healthcare sector

Other

Payout ratio

502.49%
CCEL annual payout ratio is 502.49%

Dividends paid

$2.02M
CCEL annual dividends paid is $2.02 million

Free cash flow

$2.41M
CCEL annual free cash flow is $2.41 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$31.99M
CCEL annual revenue is $31.99 million

Revenue Analysts estimate

$32.05M
CCEL annual revenue is currently -0.21% lower than the consensus analysts' forecast

Revenue 1-year change

+2.05%
CCEL annual revenue is up +2.05% year-on-year

Revenue Sector rank

40.2%
CCEL annual revenue is higher than 40.2% of companies in Healthcare sector

EPS

EPS

$0.05
CCEL annual earnings per share is $0.05

EPS Analysts estimate

-$0.08
CCEL annual earnings per share is currently -162.50% lower than the consensus analysts' forecast

EPS 1-year change

+104.35%
CCEL annual earnings per share is up +104.35% year-on-year

EPS Sector rank

83.06%
CCEL annual earnings per share is higher than 83.06% of companies in Healthcare sector

Profit

Gross profit

$24.04M
CCEL annual gross profit is $24.04 million

Gross margin

75.15%
CCEL annual gross profit margin is 75.15%

Operating profit

$3.79M
CCEL annual operating income is $3.79 million

Operating margin

11.85%
CCEL annual operating profit margin is 11.85%

Net income

$402.10K
CCEL annual net profit is $402.10 thousand

Net margin

1.26%
CCEL annual net profit margin is 1.26%

Expenses

Total expenses

$28.20M
CCEL annual total expenses is $28.20 million

Operating expenses

$20.25M
CCEL annual total operating expenses is $20.25 million

Cost of goods sold

$7.95M
CCEL annual cost of goods sold is $7.95 million

Selling, general & administrative expenses

$18.52M
CCEL annual SGA is $18.52 million

Depreciation and amortization

$1.02M
CCEL annual depreciation & amortization is $1.02 million

Interest expense

$1.86M
CCEL annual interest expense is $1.86 million

Income tax

$2.40M
CCEL annual income tax is $2.40 million

EBIT & EBITDA

EBIT

$4.67M
CCEL annual earnings before interest & taxes is $4.67 million

EBITDA

$5.69M
CCEL annual EBITDA is $5.69 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$64.68M
CCEL annual total assets is $64.68 million

Non current assets

$52.12M
CCEL annual long term assets is $52.12 million

Current assets

$12.55M
CCEL annual total current assets is $12.55 million

Cash and cash equivalents

$561.00K
CCEL annual cash & cash equivalents is $561.00 thousand

Accounts receivable

$7.31M
CCEL annual accounts receivable is $7.31 million

Inventory

$657.70K
CCEL annual inventory is $657.70 thousand

Liabilities

Total liabilities

$77.89M
CCEL annual total liabilities is $77.89 million

Long term liabilities

$56.29M
CCEL annual total long term liabilities is $56.29 million

Current liabilities

$21.60M
CCEL annual total current liabilities is $21.60 million

Accounts payable

$1.88M
CCEL annual accounts payable is $1.88 million

Debt

Total debt

$12.93M
CCEL annual total debt is $12.93 million

Total debt 1-year change

+18.7%
CCEL annual total debt is up +18.7% year-on-year

Long term debt

$8.82M
CCEL annual long term debt is $8.82 million

Short term debt

$4.12M
CCEL annual short term debt is $4.12 million

Equity & Capital

Shareholders equity

-$13.22M
CCEL annual stockholders equity is -$13.22 million

Book value

-$13.22M
CCEL annual book value is -$13.22 million

Retained earnings

-$32.78M
CCEL annual retained earnings is -$32.78 million

Working capital

-$9.04M
CCEL annual working capital is -$9.04 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$6.01M
CCEL annual cash flow from operations is $6.01 million

Cash from operations 1-year change

-32.61%
CCEL annual cash flow from operations is down -32.61% year-on-year

Cash from investing

-$4.88M
CCEL annual cash flow from investing activities is -$4.88 million

Cash from investing 1-year change

+40.12%
CCEL annual cash flow from investing activities is up +40.12% year-on-year

Cash from financing

-$979.10K
CCEL annual cash flow from financing activities is -$979.10 thousand

Cash from financing 1-year change

+52.77%
CCEL annual cash flow from financing activities is up +52.77% year-on-year

CAPEX

CAPEX

$3.60M
CCEL annual capital expenditures is $3.60 million

CAPEX 1-year change

-52.82%
CCEL annual capital expenditures is down -52.82% year-on-year

Free Cash Flow

Free cash flow

$2.41M
CCEL annual free cash flow is $2.41 million

Free cash flow 1-year change

+87.95%
CCEL annual free cash flow is up +87.95% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

75.15%
CCEL annual gross profit margin is 75.15%

Operating margin

11.85%
CCEL annual operating profit margin is 11.85%

Net margin

1.26%
CCEL annual net profit margin is 1.26%

ROA & ROE

ROA

0.64%
CCEL annual return on assets is 0.64%

ROE

-3.04%
CCEL annual return on equity is -3.04%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

603.00
CCEL price to earnings ratio is 603.00

PE ratio Sector rank

98.53%
CCEL price to earnings ratio is higher than 98.53% of companies in Healthcare sector

PB Ratio

PB ratio

-3.33
CCEL price to book ratio is -3.33

PB ratio Sector rank

5.02%
CCEL price to book ratio is higher than 5.02% of companies in Healthcare sector

PS Ratio

PS ratio

1.52
CCEL price to sales ratio is 1.52

PS ratio Sector rank

36.79%
CCEL price to sales ratio is higher than 36.79% of companies in Healthcare sector

Enterprise value

Enterprise value

$62.37M
CCEL enterprise value is $62.37 million

Enterprise value Sector rank

44.34%
CCEL enterprise value is higher than 44.34% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

10.67
CCEL EV/EBITDA is 10.67

EV/EBITDA Sector rank

83.13%
CCEL EV/EBITDA is higher than 83.13% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.58
CCEL annual current ratio is 0.58

Quick ratio

0.55
CCEL annual quick ratio is 0.55

Leverage

Debt to equity

-0.91
CCEL annual debt to equity ratio is -0.91

Interest coverage ratio

2.50
CCEL annual interest coverage ratio is 2.50

Risk & Stability

Piotroski F-Score

9
CCEL piotroski f-score is 9

Altman Z-Score

0.23
CCEL altman z-score is 0.23

Analyst ratings

Recent major analysts updates

Mar 4, 25 Maxim Group
Buy
Aug 29, 22 Maxim Group
Buy

Institutional Ownership

Similar stocks

RPTX logo
Repare Therapeutics (RPTX)
SKYE logo
Skye Bioscience (SKYE)
EDAP logo
EDAP TMS SA (EDAP)
PRE logo
Prenetics Global Limited (PRE)
GANX logo
Gain Therapeutics (GANX)
VTVT logo
vTv Therapeutics (VTVT)
VNRX logo
VolitionRx Limited (VNRX)
CUE logo
Cue Biopharma (CUE)
ICCC logo
ImmuCell (ICCC)
  • What is the ticker symbol for Cryo-Cell International?
  • Does Cryo-Cell International pay dividends?
  • What sector is Cryo-Cell International in?
  • What industry is Cryo-Cell International in?
  • What country is Cryo-Cell International based in?
  • When did Cryo-Cell International go public?
  • Is Cryo-Cell International in the S&P 500?
  • Is Cryo-Cell International in the NASDAQ 100?
  • Is Cryo-Cell International in the Dow Jones?
  • When was Cryo-Cell International's last earnings report?
  • When does Cryo-Cell International report earnings?
  • Should I buy Cryo-Cell International stock now?

What is the ticker symbol for Cryo-Cell International?

The ticker symbol for Cryo-Cell International is NASDAQ:CCEL

Does Cryo-Cell International pay dividends?

Yes, Cryo-Cell International pays dividends. The last payment was $0.25, with an ex-dividend date on February 14, 2025

What sector is Cryo-Cell International in?

Cryo-Cell International is in the Healthcare sector

What industry is Cryo-Cell International in?

Cryo-Cell International is in the Medical Care Facilities industry

What country is Cryo-Cell International based in?

Cryo-Cell International is headquartered in United States

When did Cryo-Cell International go public?

Cryo-Cell International's initial public offering (IPO) was on April 4, 1994

Is Cryo-Cell International in the S&P 500?

No, Cryo-Cell International is not included in the S&P 500 index

Is Cryo-Cell International in the NASDAQ 100?

No, Cryo-Cell International is not included in the NASDAQ 100 index

Is Cryo-Cell International in the Dow Jones?

No, Cryo-Cell International is not included in the Dow Jones index

When was Cryo-Cell International's last earnings report?

Cryo-Cell International's most recent earnings report was on Apr 15, 2025

When does Cryo-Cell International report earnings?

The date for Cryo-Cell International's next earnings report has not been announced yet

Should I buy Cryo-Cell International stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page